Based on our findings of the liver-injury patterns, no case showed typical features of autoimmune hepatitis, suggesting that corticosteroids plus immunosuppressant drugs may not be necessary in many patients who develop liver dysfunction while on anti-PD-1 therapy. The gene discussed is PDCD1; the disease is autoimmune hepatitis.